1816
V. Nagy et al. / Bioorg. Med. Chem. 20 (2012) 1801–1816
2. Moller, D. E. Nature 2001, 414, 821.
scaled by 0.80 for ligand atoms with partial atomic charge less then
0.15. Ligand poses were clustered with RMSDs less than 0.5 Å and
within maximum atomic displacement less than 1.3 Å. After the
docking procedure 20 poses of each docked ligand with the best
GlideScore49 were saved and used for the analysis.
3. Praly, J. P.; Vidal, S. Mini-Rev. Med. Chem. 2010, 10, 1102.
4. Ross, S. A.; Gulve, E. A.; Wang, M. H. Chem. Rev. 2004, 104, 1255.
5. Gershell, L. Nat. Rev. Drug Disc. 2005, 4, 367.
6. Radziuk, J.; Pye, S. Diabetes Metab. Res. Rev. 2001, 17, 250.
7. Staehr, P.; Hother-Nielsen, O.; Beck-Nielsen, H. Diabetes Obes. Metab. 2002, 4,
215.
Binding affinities were recalculated for all saved docking poses
employing the program Liaison included in the Schrodinger soft-
ware.37 The structures of the complexes using the OPLS2005 force
field50 were optimized and the LiaScore’s (‘GlideScore in Liaison’)
analyzed for the relaxed complexes. Enzyme ligand complexes
were optimized with a restrained mobility of receptor residues at
distance larger than 12 Å and with frozen residues at distance lar-
ger than 16 Å from ligand, respectively. The same DFT calculated
partial atomic charges were used for the ligand as for the docking.
Implicit solvent continuum model have been used in computation
to model solvent effects. The calculated LiaScore for the best
docked pose were correlated with the experimentally measured
lnKi values.
8. Kurukulasuriya, R.; Link, J. T.; Madar, D. J.; Pei, Z.; Richards, S. J.; Rohde, J. J.;
Souers, A. J.; Szczepankiewicz, B. G. Curr. Med. Chem. 2003, 10, 123.
9. Rotella, D. P. J. Med. Chem. 2004, 47, 4111.
10. Oikonomakos, N. G. Curr. Protein Pept. Sci. 2002, 3, 561.
11. Baker, D. J.; Greenhaff, P. L.; Timmons, J. A. Expert Opin. Ther. Patents 2006, 16,
459.
12. Gimisis, T. Mini-Rev. Med. Chem. 2010, 10, 1127.
13. Loughlin, W. A. Mini-Rev. Med. Chem. 2010, 10, 1139.
14. Chrysina, E. D. Mini-Rev. Med. Chem. 2010, 10, 1093.
15. Somsák, L. Compt. Rend. Chim. 2011, 14, 211.
16. Oikonomakos, N. G.; Kosmopolou, M.; Zographos, S. E.; Leonidas, D. D.; Somsák,
L.; Nagy, V.; Praly, J.-P.; Docsa, T.; Tóth, B.; Gergely, P. Eur. J. Biochem. 2002, 269,
1684.
17. Somsák, L.; Czifrák, K.; Tóth, M.; Bokor, É.; Chrysina, E. D.; Alexacou, K. M.;
Hayes, J. M.; Tiraidis, C.; Lazoura, E.; Leonidas, D. D.; Zographos, S. E.;
Oikonomakos, N. G. Curr. Med. Chem. 2008, 15, 2933.
18. Helferich, B.; Kosche, W. Chem. Ber. 1926, 59, 69.
19. Deng, M. Z.; Caubere, P.; Senet, J. P.; Lecolier, S. Tetrahedron 1988, 44, 6079.
20. Likhosherstov, L. M.; Novikova, O. S.; Shibaev, V. N. Dokl. Chem. 2002, 383, 89.
21. Gregoriou, M.; Noble, M. E. M.; Watson, K. A.; Garman, E. F.; Krülle, T. M.;
Fuente, C.; Fleet, G. W. J.; Oikonomakos, N. G.; Johnson, L. N. Protein Sci. 1998, 7,
915.
22. Hayes, J. M.; Leonidas, D. D. Mini-Rev. Med. Chem. 2010, 10, 1156.
23. Benltifa, M.; Hayes, J. M.; Vidal, S.; Gueyrard, D.; Goekjian, P. G.; Praly, J.-P.;
Kizilis, G.; Tiraidis, C.; Alexacou, K.-M.; Chrysina, E. D.; Zographos, S. E.;
Leonidas, D. D.; Archontis, G.; Oikonomakos, N. G. Bioorg. Med. Chem. 2009, 17,
7368.
24. Alexacou, K. M.; Hayes, J. M.; Tiraidis, C.; Zographos, S. E.; Leonidas, D. D.;
Chrysina, E. D.; Archontis, G.; Oikonomakos, N. G.; Paul, J. V.; Varghese, B.;
Loganathan, D. Proteins: Struct. Funct. Bioinform. 2008, 71, 1307.
25. Chrysina, E. D.; Chajistamatiou, A.; Chegkazi, M. Curr. Med. Chem. 2011, 18,
2620.
26. Melpidou, A. E.; Oikonomakos, N. G. FEBS Lett. 1983, 154, 105.
27. Oikonomakos, N. G.; Kontou, M.; Zographos, S. E.; Watson, K. A.; Johnson, L. N.;
Bichard, C. J. F.; Fleet, G. W. J.; Acharya, K. R. Protein Sci. 1995, 4, 2469.
28. Saheki, S.; Takeda, A.; Shimazu, T. Anal. Biochem. 1985, 148, 277.
29. Oikonomakos, N. G.; Melpidou, A. E.; Johnson, L. N. Biochim. Biophys. Acta 1985,
832, 248.
Acknowledgments
This work was supported by the Hungarian Scientific Research
Fund (OTKA T37210, T46081, CK77712) as well as by the TÁMOP
4.2.1/B-09/1/KONV-2010-0007 project co-financed by the Euro-
pean Union and the European Social Fund. Financial aid to the col-
laboration between Athens and Debrecen (GR-4/03) as well as
Lyon and Debrecen (F-11/05) was provided by GSRT (Greece) as
well as EGIDE (France), respectively, and the Agency for Research
Fund Management and Research Exploitation (KPI, Hungary), and
also by CNRS (France) and the Hungarian Academy of Sciences
(PICS 4576). VN thanks the French Embassy in Budapest for sup-
porting her co-tutored PhD Thesis prepared in Lyon and Debrecen.
Additional support for this work was provided by Greek GSRT
through ENTER-EP6/2001, PENED-204/2001, the Joint Research
and Technology Projects between Greece and Hungary (2005–
2007), Marie Curie Host Fellowship for the Transfer of Knowledge
(ToK) contact no MTKD-CT-2006-042776 under FP6; the FP7
Capacities coordination and support actions REGPOT-2008-1-No
230146 ‘EUROSTRUCT’ and REGPOT-2009-1-No 245866 ‘ARCADE’;
The research leading to these results has received funding from the
European Community’s Sixth (RII3/CT/2004/5060008, IHPP HPRI-
CT-1999-00012) and Seventh Framework Programme (FP7/2007-
2013) under grant agreement No. 226716 awarded to both SRS-
Daresbury Laboratory and EMBL-Hamburg outstation. We would
also like to thank Agence Nationale de la Recherche for funding
ANR-08-BLAN-0305 ‘GPdia’ project coordinated by JPP for support-
ing our collaborative research network and acknowledge the assis-
tance of the staff at EMBL beamlines X31, X13, BW7A, BW7B, at the
DORIS storage ring in Hamburg and at SRS-Daresbury beamline
PX9.6 for providing excellent facilities for X-ray data collection.
30. Otwinowski, Z.; Minor, W. Methods Enzymol. 1997, 276, 307.
31. Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallogr., Sect. D 1997, 53,
240.
32. Jones, T. A.; Zou, J. Y.; Cowan, S. W.; Kjeldgaard, M. Acta Crystallogr., Sect. A
1991, 47, 110.
33. Acta Crystallogr., Sect. D 1994, 50, 760.
34. Kraulis, P. J. Appl. Crystallogr. 1991, 24, 946.
35. Esnouf, R. M. J. Mol. Graphics Modell. 1997, 15, 132.
36. Merritt, E. A.; Bacon, D. J. Macromol. Crystallogr., Pt B 1997, 277, 505.
37. Schrödinger Suite, 2007. Schrödinger, Inc., Portland, OR.
38. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. J. Am. Chem. Soc. 1996, 118,
11225.
39. Becke, A. D. J. Chem. Phys. 1993, 98, 1372.
40. Lee, C. T.; Yang, W. T.; Parr, R. G. Phys. Rev. B 1988, 37, 785.
41. Ditchfield, R.; Hehre, W. J.; Pople, J. A. J. Chem. Phys. 1971, 54, 724.
42. Hehre, W. J.; Pople, J. A. J. Chem. Phys. 1972, 56, 4233.
43. Binkley, J. S.; Pople, J. A. J. Chem. Phys. 1977, 66, 879.
44. Hariharan, P. C.; Pople, J. A. Theor. Chim. Acta 1973, 28, 213.
45. Hehre, W. J.; Ditchfield, R.; Pople, J. A. J. Chem. Phys. 1972, 56, 2257.
46. Francl, M. M.; Pietro, W. J.; Hehre, W. J.; Binkley, J. S.; Gordon, M. S.; Defrees, D.
J.; Pople, J. A. J. Chem. Phys. 1982, 77, 3654.
47. Englebienne, P.; Fiaux, H.; Kuntz, D. A.; Corbeil, C. R.; Gerber-Lemaire, S.; Rose,
D. R.; Moitessier, N. Proteins: Struct. Funct. Bioinform. 2007, 69, 160.
48. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.;
Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.;
Shenkin, P. S. J. Med. Chem. 2004, 47, 1739.
49. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. J. Comput.
Aided Mol. Des. 1997, 11, 425.
50. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. J. Phys. Chem. B
2001, 105, 6474.
Supplementary data
Supplementary data (details of syntheses and crystallographic
analyses) associated with this article can be found, in the online
References and notes
1. Alberti, G.; Zimmet, P.; Shaw, J.; Bloomgarden, Z.; Kaufman, F.; Silink, M.
Diabetes Care 2004, 27, 1798.